F.D.A.’s Drug Industry Fees Fuel Concerns Over Influence

Health
By BY CHRISTINA JEWETT from NYT Health https://ift.tt/YDAkfy4
via IFTTT Drugs (Pharmaceuticals), Prices (Fares, Fees and Rates), United States Politics and Government, Law and Legislation, Clinical Trials, Generic Brands and Products, Regulation and Deregulation of Industry, Infant Formulas, Medical Devices, Lobbying and Lobbyists, Medicine and Health The pharmaceutical industry finances about 75 percent of the agency’s drug division, through a controversial program that Congress must reauthorize by the end of this month.

Comments

Post a Comment

Popular posts from this blog

F.D.A. Poised to Restrict Access to Covid Vaccines

Image
Health By Christina Jewett and Apoorva Mandavilli from NYT Health https://ift.tt/VHvAQN8 via IFTTT Vaccination and Immunization, Coronavirus (2019-nCoV), Regulation and Deregulation of Industry, Rumors and Misinformation, Clinical Trials, Medicine and Health Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many others may not be able to get the shots.
Read more

U.S. Will No Longer Recommend Covid Shots for Children and Pregnant Women

Image
Health By Apoorva Mandavilli and Christina Jewett from NYT Health https://ift.tt/lefLSPp via IFTTT Vaccination and Immunization, Children and Childhood, United States Politics and Government, Regulation and Deregulation of Industry, Babies and Infants, Pregnancy and Childbirth, Coronavirus (2019-nCoV) Health Secretary Robert F. Kennedy Jr. announced that the vaccine would not be included as part of the immunization schedule for healthy children.
Read more